What is an appropriate control group to identify risk factors for Clostridium difficile-associated diarrhoea?

被引:6
作者
Guyot, A [1 ]
Barrett, SP
机构
[1] W Middlesex Univ Hosp, Dept Microbiol, Isleworth TW7 6AF, England
[2] Charing Cross Hosp, Dept Microbiol, London W6 8RF, England
关键词
D O I
10.1093/jac/48.5.747
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:747 / 748
页数:2
相关论文
共 5 条
[1]  
GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459
[2]   Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly [J].
Guyot, A ;
Rawlins, MDM ;
Barrett, SP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :642-643
[3]   Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea [J].
MacGowan, AP ;
Feeney, R ;
Brown, I ;
McCulloch, SY ;
Reeves, DS ;
Lovering, AM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (04) :537-541
[4]  
NELSON DE, 1994, INFECT CONT HOSP EP, V15, P88
[5]   Clarithromycin and risk of Clostridium difficile-associated diarrhoea [J].
Wilcox, MH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (03) :358-359